-
DOJ charges 324 defendants in largest healthcare fraud initiative in its history
The collaborative Takedown effort targeted healthcare fraud that victimizes patients, taxpayers and government programs.
-
DOJ and HHS announce False Claims Act Working Group
Collaboration aims to advance both departments’ priority enforcement areas by sharing resources in pursuing False Claims Act violations.
-
Bupa fined A$35m in Australia for misleading customers in health insurance claims
Bupa admits to misleading thousands of health insurance customers and unconscionably denying legitimate claims over more than five years.
-
CVS Caremark’s $95m penalty for Medicare drug overbilling
Whistleblower alleged Caremark reported higher costs of drugs to the government than it paid pharmacies for dispensing Medicare Part D drugs.
-
Number of GDPR fines in EU healthcare steady, but average fine rises steeply
Deep dive into the life science and healthcare findings from the CMS GDPR Enforcement Tracker Report 2025.
-
Pharmaceutical Compliance Congress: Panelists spot trends to prioritize in 2025
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
-
Kudman and Posner discuss best practices in healthcare compliance
Our conversation took in good training programs, the OIG’s compliance guidelines, the importance of communication, and more.
-
Tackling fraud in Big Pharma: Realistic ambition or pipe dream?
Any suggestion of misleading clinical results, false advertising, or bribery to achieve medical approvals would clearly create massive negative publicity.